Free Republic 2nd Qtr 2024 Fundraising Target: $81,000 Receipts & Pledges to-date: $21,223
26%  
Woo hoo!! And we're now over 26%!! Thank you all very much!! God bless.

Keyword: ranbaxy

Brevity: Headers | « Text »
  • CLINTON FOUNDATION SENT BAD DRUGS TO THIRD WORLD

    09/22/2016 3:08:43 AM PDT · by Biggirl · 17 replies
    Frontpagemag.com ^ | September 22, 2016 | Daniel Greenfield
    Every time you think that the Clintons can't get any lower, they get lower and then lower still. And then they find a sewer below it to swim in. Do you think the Clintons have gotten as low as it's possible for human beings to get? Grifters gotta grift. And monsters have to do things like this. The CHAI program to help AIDS victims is considered one of the Clinton Foundation’s most important contributions and is probably its best known initiative. The congressional report focused on Clinton’s decade-long relationship with a controversial Indian drug manufacturer called Ranbaxy, which CHAI used...
  • FDA warns on Ranbaxy Indian-made drugs [CostCo drug provider]

    09/16/2008 12:38:20 PM PDT · by calcowgirl · 14 replies · 1,014+ views
    MarketWatch ^ | Sept. 16, 2008 | Val Brickates Kennedy
    Last update: 3:30 p.m. EDT BOSTON (MarketWatch) -- The Food and Drug Administration said Tuesday that it has determined that two Indian manufacturing plants operated by Indian drugmaker Ranbaxy Laboratories Ltd. are not in compliance due to "serious manufacturing deficiencies." As a result, U.S. border officials may detain any products made at the facilities ... The plants make active ingredients for more than 30 generic drugs. ...
  • How Good Are Your Drugs? (Part 4)

    06/26/2007 5:50:31 AM PDT · by Rick Vassar · 147+ views
    As we dig deeper into the issue of prescription drug safety and the multitude of issues surrounding the manufacture, distribution and profit from pharmaceuticals in the United States, it is becoming increasingly evident that Congressional members are under pressure to make the approval process easier. Part One of this series looks at the gaps in the worldwide distribution systems of pharmaceuticals. Part Two examines the breakdown in oversight of the manufacturing process by the federal government. Part Three gives a glaring example of how state governments are dropping the ball. Now, we expand the scope even further. While Michael Moore's...